Your browser doesn't support javascript.
loading
Botulinum Toxin for the Management of Sjögren Syndrome-Associated Recurrent Parotitis.
O'Neil, Luke M; Palme, Carsten E; Riffat, Faruque; Mahant, Neil.
Affiliation
  • O'Neil LM; Resident, Department of Surgery, Blacktown Hospital, Sydney, New South Wales, Australia. Electronic address: lm.oneil3@gmail.com.
  • Palme CE; Associate Professor and Otorhinolaryngologist, Department of Otolaryngology, Head and Neck Surgery, Crown Princess Mary Cancer Care Centre, and Sydney Medical School, Westmead Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Riffat F; Otorhinolaryngologist, Department of Otolaryngology, Head and Neck Surgery, Crown Princess Mary Cancer Care Centre, and Sydney Medical School, Westmead Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Mahant N; Neurologist, Sydney Medical School and Department of Neurology, Westmead Hospital, Sydney, New South Wales, Australia.
J Oral Maxillofac Surg ; 74(12): 2428-2430, 2016 Dec.
Article in En | MEDLINE | ID: mdl-27400144
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parotitis / Sjogren's Syndrome / Botulinum Toxins, Type A / Neuromuscular Agents Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: J Oral Maxillofac Surg Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parotitis / Sjogren's Syndrome / Botulinum Toxins, Type A / Neuromuscular Agents Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: J Oral Maxillofac Surg Year: 2016 Type: Article